RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)

NACompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

May 14, 2018

Primary Completion Date

November 4, 2020

Study Completion Date

September 28, 2022

Conditions
Coronary Artery Disease
Interventions
DEVICE

Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System

Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System, sizes 2.0 mm - 5.0 mm

Trial Locations (25)

3600

Ziekenhuis Oost Limburg, Genk

6042

CHU Charleroi, Charleroi

10016

NYU Langone Medical Center, New York

11030

North Shore University Hospital, Manhasset

22903

University of Virginia Medical Center, Charlottesville

33756

Morton Plant Hospital, Clearwater

54301

Saint Vincent Hospital, Green Bay

77030

Houston Methodist Hospital, Houston

92037

Scripps Green Hospital, La Jolla

97401

Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s, Banská Bystrica

35801-4421

Huntsville Hospital, Huntsville

92506-0102

Riverside Community Hospital, Riverside

06106-5527

Hartford Hospital, Hartford

32605-4524

North Florida Regional Medical Center, Gainesville

32308-4646

Tallahassee Memorial Hospital, Tallahassee

30060-1125

WellStar Kennestone Hospital, Marietta

48109-5869

University of Michigan Health System, Ann Arbor

55433-4568

Mercy Hospital, Coon Rapids

55407-1195

Abbott Northwestern, Minneapolis

68198-2265

Nebraska Medical Center, Omaha

89118-3011

Desert Springs Hospital, Las Vegas

13057-9208

St. Josephs Hospital Health Center, East Syracuse

10032-3729

New York-Presbyterian Hospital/ Columbia University Medical Center, New York

38138-1727

Baptist Memorial Hospital-Memphis, Germantown

50032 31059

CHU Toulouse - Hôpital Rangueil, Toulouse

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY